Skip to main content

and
  1. Article

    Open Access

    Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Despite the proven efficacy of combined immunochemotherapy (R-CHOP) in the majority of patients, ~40% of DLBCL patients do not respond...

    Myra Langendonk, Mathilde R. W. de Jong, Nienke Smit, Jonas Seiler in Blood Cancer Journal (2022)